From left, UVA President Jim Ryan, Gov. Glenn Youngkin, Paul Manning, UVA Health CEO Dr. K. Craig Kent and University Rector Whitt Clement answer media questions following Friday’s announcement. (Photo by Erin Edgerton, University Communications)

UVA Leverages $100 Million Gift To Launch Paul and Diane Manning Institute of Biotechnology To Transform Health Care

Virginia Gov. Glenn Youngkin joined UVA and other state and federal leaders in hailing the institute as a major victory for Virginia’s residents and its economy.

UVA Today

UVA Leverages $100 Million Gift To Launch Paul and Diane Manning Institute of Biotechnology To Transform Health Care
image of a woman with her glasses off, holding her brow

UVA Solves Mysteries About Leading Biomarker for Alzheimer’s

The new discovery advances the battle against the disease, which strikes 1 in 9 people over age 65.

UVA Today

UVA Solves Mysteries About Leading Biomarker for Alzheimer’s
pregnant mother next to a picture of medications

Mother’s Antidepressant Use, Plus Infection, Linked to Neurodevelopmental Disorders

The findings might help to explain the rise in autism prevalence over the last 20 years, researchers said.

UVA Today

Mother’s Antidepressant Use, Plus Infection, Linked to Neurodevelopmental Disorders
COVID-19 Booster Increases Durability of Antibody Response

COVID-19 Booster Increases Durability of Antibody Response

New research from the University of Virginia School of Medicine speaks to the benefits of a COVID-19 booster.

UVA Health Newsroom

COVID-19 Booster Increases Durability of Antibody Response
illustration of cdiff

GUT BACTERIA CAN MAKE C. DIFF INFECTIONS WORSE

With Moderna’s recent success in a skin cancer vaccine trial, Dr. Craig Slingluff explains how such therapies work and reports on UVA’s own vaccine development.

UVA Today

Q&A: In the Race for a Melanoma Vaccine, UVA Has Skin in the Game